Structure and function of V-ATPases in osteoclasts: Potential therapeutic targets for the treatment of osteolysis

Histology and Histopathology

Volumn 22, Issue 4-6, 2007, Pages 443-454

  Xu, Jiake ^a   Cheng, T ^a   Feng, H T ^a   Pavlos, N J ^a   Zheng, M H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Bone resorption; Osteoclast; Osteolysis; V ATPases; V ATPases inhibitors

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; BAFILOMYCIN A1; BENZOLACTONE ENAMIDE; CONCANAMYCIN A; DESTRUXIN B; ESTROGEN; FR 167356; LOBATAMIDE; METHOBENZOXAZOLE; NITROBENZIMIDAZOLE; NITROBENZOTHIAZOLE; OMEPRAZOLE; OXIMIDINE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SALICYLIHALAMIDE A; SB 242784; UNCLASSIFIED DRUG; ENZYME INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ACIDIFICATION; ALBERS SCHOENBERG DISEASE; APOPTOSIS; CELL FUNCTION; DRUG STRUCTURE; DRUG TARGETING; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME STRUCTURE; ENZYME SUBUNIT; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE;

LACUNA; MUS;

ANIMALS; ENZYME INHIBITORS; HUMANS; MICE; MOLECULAR STRUCTURE; OSTEOCLASTS; OSTEOLYSIS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 33947513226     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Adachi I., Puopolo K., Marquez-Sterling N., Arai H. and Forgac M. (1990). Dissociation, cross-linking, and glycosylation of the coated vesicle proton pump. J. Biol. Chem. 265, 967-973.
2. Arai H., Terres G., Pink S. and Forgac M. (1988). Topography and subunit stoichiometry of the coated vesicle proton pump. J. Biol. Chem. 263, 8796-8802.
3. +-ATPase. J. Biol. Chem. 277, 3357-3363.
4. Arata Y., Nishi T., Kawasaki-Nishi S., Shao E., Wilkens S. and Forgac M. (2002b). Structure, subunit function and regulation of the coated vesicle and yeast vacuolar (H(+))-ATPases. Biochim. Biophys. Acta 1555, 71-74.
5. Baron R. (1989). Molecular mechanisms of bone resorption by the osteoclast. Anat. Rec. 224, 317-324.
6. Baron R., Neff L., Louvard D. and Courtoy P.J. (1985). Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 101, 2210-2222.
7. Bauerle C., Ho M.N., Lindorfer M.A. and Stevens T.H. (1993). The Sacchammyces cemvisiae VMA6 gene encodes the 36-kDa subunit of the vacuolar H(+)-ATPase membrane sector. J. Biol. Chem. 268, 12749-12757.
8. 2+-releasing channel. J. Cell Biol. 162, 211-222.
9. Blair H.C., Teitelbaum S.L., Ghiselli R. and Gluck S. (1989). Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245, 855-857.
10. Bowman B.J. and Bowman E.J. (2002). Mutations in subunit C of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site. J. Biol. Chem. 277, 3965-3972.
11. Bowman E.J., Graham L.A., Stevens T.H. and Bowman B.J. (2004). The bafilomycin/concanamycin binding site in subunit c of the V-ATPases from Neurospora crassa and Saccharomyces cerevisiae. J. Biol. Chem. 279, 33131-33138.
12. +)-atpases. J. Pharmacol. Exp. Ther. 297, 114-120.
13. + ATPases. Proc. Natl. Acad. Sci. USA 89, 6257-6261.
14. +-ATPase binding to microfilaments: regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B. J. Biol. Chem. 279, 7988-7998.
15. 0 subunit of the yeast V-ATPase. J. Biol. Chem. 281, 15312-15319
16. Demirci F.Y., White N.J., Rigatti B.W., Lewis K.F. and Gorin M.B. (2001). Identification, genomic structure, and screening of the vacuolar proton-ATPase membrane sector-associated protein M8-9 gene within the COD1 critical region (Xp11.4). Mol. Vis. 7, 234-239.
17. +-ATPase have normal hearing. Hear Res. 180, 76-84.
18. +-ATPase isolated from human gastric mucosa. Scand. J. Gastroenterol. 21, 268-272.
19. Farina C. and Gagliardi S. (1999). Selective inhibitors of the osteoclast vacuolar proton ATPase as novel bone antiresorptive agents. Drug Discov. Today 4, 163-172.
20. Farina C. and Gagliardi S. (2002). Selective inhibition of osteoclast vacuolar H(+)-ATPase. Curr. Pharm. Des. 8, 2033-2048.
21. +)ATPase. Nature 290, 159-161.
22. Finbow M.E., Eliopoulos E.E., Jackson P.J., Keen J.N., Meagher L., Thompson P., Jones P. and Findlay J.B. (1992). Structure of a 16 kDa integral membrane protein that has identity to the putative proton channel of the vacuolar H(+)-ATPase. Protein Eng. 5, 7-15.
23. +)-ATPases. J. Biol. Chem. 274,12951-12954.
24. Frattini A., Orchard P.J., Sobacchi C., Giliani S., Abinun M., Mattsson J.P., Keeling D.J., Andersson A.K., Wallbrandt P., Zecca L., Notarangelo L.D., Vezzoni P. and Villa A. (2000). Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25, 343-346.
25. +-ATPase of osteoclasts with bone antiresorptive activity. J. Med. Chem. 41, 1568-1573.
26. Grinstein S., Nanda A., Lukacs G. and Rotstein O. (1992). V-ATPases in phagocytic cells. J. Exp. Biol. 172, 179-192.
27. Henriksen K., Gram J., Schaller S., Dahl B.H., Dziegiel M.H., Bollerslev J. and Karsdal M.A. (2004). Characterization of osteoclasts from patients harboring a G215R mutation in CIC-7 causing autosomal dominant osteopetrosis type II. Am. J. Pathol. 164, 1537-1545.
28. Henriksen K., Sorensen M.G., Nielsen R.H., Giram J., Schaller S., Dziegiel M.H., Everts V., Bollerslev J. and Karsdal M.A. (2006). Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J. Bone Miner. Res. 21, 58-66.
29. 0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 121, 607-620.
30. +-ATPase. J. Biol. Chem. 272, 4795-4803.
31. Hirata T., Iwamoto-Kihara A., Sun-Wada G.H., Okajima T., Wada Y. and Futai M. (2003). Subunit rotation of vacuolar-type proton pumping ATPase: relative rotation of the G and C subunits. J. Biol. Chem. 278, 23714-23719.
32. +-ATPase contains a filamentous actin binding site. J. Biol. Chem. 275, 32331-32337.
33. Hurtado-Lorenzo A., Skinner M., EI Annan J., Futai M., Sun-Wada G.H., Bourgoin S., Casanova J., Wildeman A., Bechoua S., Ausiello D.A., Brown D. and Marshansky V. (2006). V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol. 8, 124-136.
34. Huss M., Ingenhorst G., Konig S., Gassel M., Drose S., Zeeck A., Altendorf K. and Wieczorek H. (2002). Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c. J. Biol. Chem. 277, 40544-40548.
35. 1-ATPase. Proc. Natl. Acad. Sci. USA 100, 2312-2315.
36. Inoue H., Noumi T., Nagata M., Murakami H. and Kanazawa H. (1999). Targeted disruption of the gene encoding the proteolipid subunit of mouse vacuolar H(+)-ATPase leads to early embryonic lethality. Biochim. Biophys. Acta 1413, 130-138.
37. +-ATPase accessory subunit Ac45. J. Cell Sci. 111, 2999-3006.
38. +-ATPase cause renal tubular acidosis with sensorineural deafness. Nat. Genet. 21, 84-90.
39. Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., Schmitt A., Poet M., Steinfeld R., Schweizer M., Kornak U. and Jentsch T.J. (2005). Loss of the chloride channel CIC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24, 1079-1091.
40. Kawasaki-Nishi S., Nishi T. and Forgac M. (2001). Arg-735 of the 100-kDa subunit a of the yeast V-ATPase is essential for proton translocation. Proc. Natl. Acad. Sci. USA 98, 12397-12402.
41. Kinashi H., Sakaguchi K., Higashijima T. and Miyazawa T. (1982). Structures of concanamycins B and C. J. Antibiot. (Tokyo) 35, 1618-1620.
42. Kinashi H., Someno K. and Sakaguchi K. (1984). Isolation and characterization of concanamycins A, B and C. J. Antibiot (Tokyo). 37, 1333-1343.
43. Kontani K., Moskowitz I.P.G. and Rothman J.H. (2005). Repression of Cell-Cell Fusion by Components of the C. elegans Vacuolar ATPase Complex. Developmental Cell 8, 787-794.
44. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., Friedrich W., Delling G. and Jentsch T.J. (2001). Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205-215.
45. Laitala-Leinonen T., Lowik C., Papapoulos S. and Vaananen H.K. (1999). Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro. J. Cell Sci. 112, 3657-3666.
46. 1 sector. J. Biol. Chem. 275, 15449-15457.
47. Lange P.F., Wartosch L., Jentsch T.J. and Fuhrmann J.C. (2006). CIC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440, 220-223.
48. Lee B.S., Holliday L.S., Ojikutu B., Krits I. and Gluck S.L. (1996). Osteoclasts express the B2 isoform of vacuolar H(+)-ATPase intracellularly and on their plasma membranes. Am. J. Physiol. 270, C382-388.
49. Leng X.H., Nishi T. and Forgac M. (1999). Transmembrane topography of the 100-kDa a subunit (Vph1p) of the yeast vacuolar proton-translocating ATPase. J. Biol. Chem. 274, 14655-14661.
50. Li Y.P., Chen W., Liang Y., Li E. and Stashenko P. (1999). Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23, 447-451.
51. Liu Q., Kane P.M., Newman P.R. and Forgac M. (1996). Site-directed mutagenesis of the yeast V-ATPase B subunit (Vma2p). J. Biol. Chem. 271, 2018-2022.
52. +-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. J. Biol. Chem. 276, 30407-30413.
53. Lu M., Vergara S., Zhang L., Holliday L.S., Aris J. and Gluck S.L. (2002). The amino-terminal domain of the E subunit of vacuolar H(+)-ATPase (V- ATPase) interacts with the H subunit and is required for V-ATPase function. J. Biol. Chem. 277, 38409-38415.
54. Ludwig J., Kerscher S., Brandt U., Pfeiffer K., Getlawi F., Apps D.K. and Schagger H. (1998). Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 273, 10939-10947.
55. MacLeod K.J., Vasilyeva E., Baleja J.D. and Forgac M. (1998). Mutational analysis of the nucleotide binding sites of the yeast vacuolar proton-translocating ATPase. J. Biol. Chem. 273, 150-156.
56. Manolson M., Wu B., Proteau D., Taillon B., Robeds B., Hoyt M. and Jones E. (1994). STV1 gene encodes functional homologue of 95-kDa yeast vacuolar H(+)- ATPase subunit Vph1p. J. Biol. Chem. 269, 14064-14074.
57. Manolson M.F., Yu H., Chen W., Yao Y., Li K., Lees R.L. and Heersche J.N. (2003). The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (>or=10 nuclei) and small (
58. Martinez-Zaguilan R., Lynch R.M., Martinez G.M. and Gillies R.J. (1993). Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. 265, C1015-1029.
59. +-ATPase B-subunit using isoform-specific antibodies. J. Bone Miner. Res. 12, 753-760.
60. Miura G.I., Froelick G.J., Marsh D.J., Stark K.L. and Palmiter R.D. (2003). The d subunit of the vacuolar ATPase (Atp6d) is essential for embryonic development. Transgenic Res. 12, 131-133.
61. Miura K., Miyazawa S., Furuta S., Mitsushita J., Kamijo K., Ishida H., Miki T., Suzukawa K., Resau J., Copeland T.D. and Kamata T. (2001). The Sos1-Rac1 signaling. Possible involvement of a vacuolar H(+)-ATPase E subunit. J. Biol. Chem. 276, 46276-46283.
62. +ATPase a subunit to nerve terminals where it associates with both synaptic vesicles and the presynaptic plasma membrane. J. Cell Sci. 116, 4751-4762.
63. Muroi M., Shiragami N. and Takatsuki A. (1994). Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase. Biochem. Biophys. Res. Commun. 205, 1358-1365.
64. Nelson N. (1992). Structural conservation and functional diversity of V-ATPases. J. Bioenerg Biomembr. 24, 407-414.
65. Niikura K., Takano M. and Sawada M. (2004). A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase. Br. J. Pharmacol. 142, 558-566.
66. Niikura K., Takeshita N. and Chida N. (2005a). A novel inhibitor of vacuolar ATPase, FR202126, prevents alveolar bone destruction in experimental periodontitis in rats. J. Toxicol. Sci. 30, 297-304.
67. Niikura K., Takeshita N. and Takano M. (2005b). A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application. J. Bone Miner. Res. 20, 1579-1588.
68. Nishi T. and Forgac M. (2000). Molecular cloning and expression of three isoforms of the 100-kDa a subunit of the mouse vacuolar proton-translocating ATPase. J. Biol. Chem. 275, 6824-6830.
69. +)-ATPases - nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 3, 94-103.
70. Nishi T., Kawasaki-Nishi S. and Forgac M. (2003). Expression and function of the mouse V-ATPase d subunit isoforms. J. Biol. Chem. 278, 46396-46402.
71. Perin M.S., Fried V.A., Stone D.K., Xie X.S. and Sudhof T.C. (1991). Structure of the 116-kDa polypeptide of the clathrin-coated vesicle/ synaptic vesicle proton pump. J. Biol. Chem. 265, 3877-3881.
72. Peters C., Bayer M.J., Buhler S., Andersen J.S., Mann M. and Mayer A. (2001). Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 409, 581-588.
73. Phan T.C., Xu J. and Zheng M.H. (2004). Interaction between osteoblast and osteoclast: impact in bone disease. Histol. Histopathol. 19, 1325-1344.
74. Sambade M. and Kane P.M. (2004). The yeast vacuolar proton-translocating ATPase contains a subunit homotogous to the manduca sexta and Bovine e Subunits That is essential for function. J. Biol. Chem. 279, 17361-17385.
75. Schoonderwoert V.T. and Martens G.J. (2002). Targeted disruption of the mouse gene encoding the V-ATPase accessory subunit Ac45. Mol. Membr. Biol. 19, 67-71.
76. Smith A.N., Skaug J., Choate K.A., Nayir A., Bakkaloglu A., Ozen S., Hulton S.A., Sanjad S.A., Al-Sabban E.A., Lifton R.P., Scherer S.W. and Karet F.E. (2000). Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat. Genet. 26, 71-75.
77. Smith A.N., Borthwick K.J. and Karet F.E. (2002). Molecular cloning and characterization of novel tissue-specific isoforms of the human vacuolar H(+)-ATPase C, G and d subunits, and their evaluation in autosomal recessive distal renal tubular acidosis. Gene 297, 169-177.
78. + -ATPase subunit genes. Mol. Cell. 12, 801-803.
79. Snider B.B. and Song F. (2000). Synthesis of the N-((1E)-alkenyl)-(2Z,4Z)-heptadienamide side chain of salicylihalamide A and apicularens A and B. Org. Lett. 2, 407-408.
80. Sobacchi C., Frattini A., Orchard P., Porras O., Tezcan I., Andolina M., BabuI-Hirji R., Baric I., Canham N., Chitayat D., Dupuis-Girod S., Ellis I., Etzioni A., Fasth A., Fisher A., Gerritsen B., Gulino V., Horwitz E., Klamroth V., Lanino E., Mirolo M., Musio A., Matthijs G., Nonomaya S., Notarangelo L.D., Ochs H.D., Superti Furga A., Valiaho J., van Hove J.L., Vihinen M., Vujic D., Vezzoni P. and Villa A. (2001). The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum. Mol. Genet. 10, 1767-1773.
81. +)-ATPase. Annu. Rev. Cell Dev. Biol. 13, 779-808.
82. Stover E.H., Borthwick K.J., Bavalia C., Eady N., Fritz D.M., Rungroj N., Giersch A.B., Morton C.C., Axon P.R., Akil I., Al-Sabban E.A., Baguley D.M., Bianca S., Bakkaloglu A., Bircan Z., Chauveau D., Clermont M.J., Guala A., Hulton S.A., Kroes H., Li Volti G., Mir S., Mocan H., Nayir A., Ozen S., Rodriguez Soriano J., Sanjad S.A., Tasic V., Taylor C.M., Topaloglu R., Smith A.N. and Karet F.E. (2002). Novel ATP6V1B1 and ATP6VOA4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet. 39, 796-803.
83. Sundquist K.T. and Marks S.C., Jr. (1994). Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo. J. Bone Miner. Res. 9, 1575-1582.
84. Sundquist K., Lakkakorpi P., Wallmark B. and Vaananen K. (1990). Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. Biochem. Biophys. Res. Commun. 168, 309-313.
85. Supek F., Supekova L., Mandiyan S., Pan Y.C., Nelson H. and Nelson N. (1994). A novel accessory subunit for vacuolar H(+)-ATPase from chromaffin granules. J. Biol. Chem. 269, 24102-24106.
86. + ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages. J. Cell Physiol. 157, 453-460.
87. Teitelbaum S.L. (2000). Bone resorption by osteoclasts. Science 289, 1504-1508.
88. Toyomura T., Oka T., Yamaguchi C., Wada Y. and Futai M. (2000). Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J. Biol. Chem. 275, 8760-8765.
89. Vaananen H.K., Zhao H., Mulari M. and Halleen J.M. (2000). The cell biology of osteoclast function. J. Cell Sci. 113, 377-381.
90. Vasilyeva E., Liu Q., MacLeod K.J., Baleia J.D. and Forgac M. (2000). Cysteine scanning mutagenesis of the noncatalytic nucleotide binding site of the yeast V-ATPase. J. Biol. Chem. 275, 255-260.
91. Visentin L., Dodds R.A., Valente M., Misiano P., Bradbeer J.N., Oneta S., Liang X., Gowen M. and Farina C. (2000). A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J. Clin. Invest. 106, 309-318.
92. Vitavska O., Wieczorek H. and Merzendorfer H. (2003). A novel role for subunit C in mediating binding of the H(+)-V-ATPase to the actin cytoskeleton. J. Biol. Chem. 278, 18499-505.
93. Wang Y., Inoue T. and Forgac M. (2005). Subunit a of the yeast V-ATPase participates in binding of bafilomycin. J. Biol. Chem. 280, 40481-40488.
94. Werner G., Hagenmaier H., Drautz H., Baumgartner A. and Zahner H. (1984). Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J. Antibiot. (Tokyo) 37, 110-117.
95. Wilkens S. and Forgac M. (2001). Three-dimensional structure of the vacuolar ATPase proton channel by electron microscopy. J. Biol. Chem. 276, 44064-44068.
96. Wu Y., Liao X., Wang R., Xie X.S. and De Brabander J.K. (2002). Total synthesis and initial structure-function analysis of the potent V-ATPase inhibitors salicylihalamide A and related compounds. J. Am. Chem. Soc. 124, 3245-3253.
97. 0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1. J. Biol. Chem. 279, 19755-19763.
98. Xu J., Feng H.T., Wang C., Yip K.H., Pavios N., Papadimitriou J.M., Wood D. and Zheng M.H. (2003). Effects of Bafilomycin A1: An inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts. J. Cell. Biochem. 88, 1256-1264.
99. Xu T., Vasilyeva E. and Forgac M. (1999). Subunit interactions in the clathrin-coated vesicle vacuolar (H(+))-ATPase complex. J. Biol. Chem. 274, 28909-28915.
100. Yokoyama K., Nakano M, Imamura H., Yoshida M. and Tamakoshi M. (2003). Rotation of the proteolipid ring in the V-ATPase. J. Biol. Chem. 278, 24255-24258.
101. 0 domain of the coated vesicle V-ATPase. J. Biol. Chem. 269, 23518-23523.
102. Zheng M.H., Robbins P., Xu J., Huang L., Wood D.J. and Papadimitriou J.M. (2001). The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol. Histopathol. 16, 297-307.